The Duration and Determinants of Anti-SARS-CoV-2 Immunoglobulin G in Cancer Patients with SARS-CoV-2 Infection: A Longitudinal Study

Patients with cancer have an increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and a high case-fatality rate. The duration of anti-SARS-CoV-2 immunoglobulin G (IgG) antibodies in cancer patients following SARS-CoV-2 infection has not been reported previously. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yao, Zhao, Yingchao, Li, Guiling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242909/
https://www.ncbi.nlm.nih.gov/pubmed/35767154
http://dx.doi.org/10.1007/s00284-022-02933-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242909/
https://www.ncbi.nlm.nih.gov/pubmed/35767154
http://dx.doi.org/10.1007/s00284-022-02933-2

Ejemplares similares